Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

KKura Oncology, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
K

Kura Oncology, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $20.87M. Net result −$68.33M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $20.87M. Running result $20.87M. License And Collaboration Revenue: $11.75M. Product: $9.12M.
  • Cost of revenue: −$243K. Running result $20.63M.
  • Gross profit: $20.63M. Running result $20.63M.
  • Research and development: −$61.89M. Running result −$41.26M.
  • Selling, general and administrative: −$31.75M. Running result −$73.01M.
  • Operating income: −$73.01M. Running result −$73.01M.
  • Other income: $4.69M. Running result −$68.32M.
  • Pre-tax loss: −$68.32M. Running result −$68.32M.
  • Income tax expense: −$5K. Running result −$68.33M.
  • Net loss: −$68.33M. Running result −$68.33M.